<DOC>
	<DOC>NCT02726048</DOC>
	<brief_summary>This investigation is designed to evaluate the performance, comfort and ease of use of the Simplus and Eson masks amongst NIV patients who are currently on Bi-level therapy</brief_summary>
	<brief_title>Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - Germany</brief_title>
	<detailed_description>Up to 40 NIV patients who currently use a full face mask or a nasal mask will be recruited. They will be issued a Simplus (if they are existing full face users) or Eson (if they are existing nasal users) to use in-home for 2 weeks. This will consists of male and female participants who have been prescribed with NIV therapy for at least 3 months.</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<mesh_term>Hypoventilation</mesh_term>
	<mesh_term>Neuromuscular Diseases</mesh_term>
	<mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
	<criteria>Aged 18+ Existing full face mask user or a nasal mask user Prescribed NIV therapy for at least 3 months Inability to give informed consent Pregnant or think they may be pregnant Anatomical or physiological conditions making NIVtherapy inappropriate Patients who are in a coma or decreased level of consciousness Existing Simplus and Eson users</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>